Gopal Krishna

Publication Activity (10 Years)

Years Active: 2020-2020
Publications (10 Years): 4

Top Topics

Placebo Controlled

Coronary Artery

Top Venues

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Ken Ogasawara, Christine Xu, Vanaja Kanamaluru, Nicholas Siebers, Sekhar Surapaneni, Laurence Ridoux, Maria Palmisano, Gopal Krishna
Excretion balance and pharmacokinetics following a single oral dose of [14C]-fedratinib in healthy subjects. Cancer chemotherapy and pharmacology 86 (2) (2020)
Ken Ogasawara, Christine Xu, Vanaja Kanamaluru, Maria Palmisano, Gopal Krishna
Effects of repeated oral doses of ketoconazole on a sequential ascending single oral dose of fedratinib in healthy subjects. Cancer chemotherapy and pharmacology 85 (5) (2020)
Ken Ogasawara, William B Smith, Christine Xu, Jian Yin, Maria Palmisano, Gopal Krishna
Pharmacokinetics and tolerability of fedratinib, an oral, selective Janus kinase 2 inhibitor, in subjects with renal or hepatic impairment. Cancer chemotherapy and pharmacology 85 (6) (2020)
Ken Ogasawara, Patricia M LoRusso, Anthony J Olszanski, Olivier Rixe, Christine Xu, Jian Yin, Maria Palmisano, Gopal Krishna
Assessment of effects of repeated oral doses of fedratinib on inhibition of cytochrome P450 activities in patients with solid tumors using a cocktail approach. Cancer chemotherapy and pharmacology 86 (1) (2020)